UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

 

Commission File Number  

000-10093

 

Fuse Medical, Inc.

(Exact name of issuer as specified in its charter)

 

1565 N. Central Expressway, Suite 220, Richardson, Texas

(469) 862-3030

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock

(Title of each class of securities covered by this Form)

 

N/A

(Title of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

 

Rule 12g-4(a)(1)

☒

        
 

Rule 12g-4(a)(2)

☐

        
 

Rule 12h-3(b)(1)(i)

☐

        
 

Rule 12h-3(b)(1)(ii)

☐

        
 

Rule 15d-6

☐

        
 

Rule 15d-22(b)

☐

        

 

Approximate number of holders of record as of the certification or notice date: 298

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Fuse Medical, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date:

September 27, 2023

  

By:

/s/ Lawrence S. Yellin

  
       

Lawrence S. Yellin

  
       

Chief Financial Officer

  

 

 
Fuse Medical (PK) (USOTC:FZMD)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Fuse Medical (PK).
Fuse Medical (PK) (USOTC:FZMD)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Fuse Medical (PK).